Literature DB >> 3366469

The C8-binding protein of human erythrocytes: interaction with the components of the complement-attack phase.

S Schönermark1, S Filsinger, B Berger, G M Hänsch.   

Abstract

C8-binding protein is an intrinsic membrane protein of the human erythrocyte. It inhibits the complement (C5b-9)-mediated lysis in a species-restricting manner. In the present study we incorporated C8bp, isolated from human erythrocytes, into sheep erythrocytes (SRBC). SRBC, normally sensitive to lysis by human C5b-9, became insensitive to lysis. Furthermore, we found that C8bp is incorporated into the membrane-attack complex C5b-9, most probably by interacting with C8, since C8bp has an affinity for C8, particularly for the C8 alpha-gamma-subunit. Antibodies to C8bp react with the C8 alpha-subunits and with C9, pointing to the possibility of a partial homology between these proteins.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3366469      PMCID: PMC1454802     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  22 in total

1.  Isolation of late complement components by affinity chromatography: I. Purification of the human complement component C9 and production of a C9-defective human serum.

Authors:  E W Rauterberg; C Schieck; G Hänsch
Journal:  Z Immunitatsforsch Immunobiol       Date:  1979-06

2.  Lytic activity of C5-9 complexes for erythrocytes from the species other than sheep: C9 rather than C8-dependent variation in lytic activity.

Authors:  K I Yamamoto
Journal:  J Immunol       Date:  1977-10       Impact factor: 5.422

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.

Authors:  A Nicholson-Weller; J Burge; D T Fearon; P F Weller; K F Austen
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

5.  Homologous species restriction in lysis of erythrocytes by terminal complement proteins.

Authors:  G M Hänsch; C H Hammer; P Vanguri; M L Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

6.  Molecular analysis of the reaction of C9 with EAC1-8: reaction of C9 with EAC1-8.

Authors:  H Kitamura; S Inai
Journal:  J Immunol       Date:  1974-12       Impact factor: 5.422

7.  Binding of the eighth component of human complement to the soluble cytolytic complex is mediated by its beta subunit.

Authors:  J B Monahan; J M Sodetz
Journal:  J Biol Chem       Date:  1980-11-25       Impact factor: 5.157

8.  Circular polymerization of the ninth component of complement. Ring closure of the tubular complex confers resistance to detergent dissociation and to proteolytic degradation.

Authors:  E R Podack; J Tschopp
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

9.  The eighth component of human complement. Purification and physicochemical characterization of its unusual subunit structure.

Authors:  E W Steckel; R G York; J B Monahan; J M Sodetz
Journal:  J Biol Chem       Date:  1980-12-25       Impact factor: 5.157

10.  Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9.

Authors:  G M Hänsch; S Schönermark; D Roelcke
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

View more
  12 in total

1.  Homologous species restriction of the complement-mediated killing of nucleated cells.

Authors:  H Yamamoto; P Blaas; A Nicholson-Weller; G M Hänsch
Journal:  Immunology       Date:  1990-08       Impact factor: 7.397

2.  C8 binding protein bears I antigenic determinants.

Authors:  P Blaas-Mautner; S Filsinger; B Berger; D Roelcke; G M Hänsch
Journal:  Ann Hematol       Date:  1991 Feb-Mar       Impact factor: 3.673

Review 3.  Red blood cells as an efficient in vitro model for evaluating the efficacy of metallic nanoparticles.

Authors:  Ridhima Wadhwa; Taru Aggarwal; Noopur Thapliyal; Ashutosh Kumar; Pooja Yadav; Vandana Kumari; Boda Sai Charan Reddy; Pranjal Chandra; Pawan Kumar Maurya
Journal:  3 Biotech       Date:  2019-06-21       Impact factor: 2.406

Review 4.  Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects.

Authors:  B P Morgan
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

Review 5.  Membrane proteins that protect against complement lysis.

Authors:  B P Morgan; S Meri
Journal:  Springer Semin Immunopathol       Date:  1994

Review 6.  Association of Blood Group Antigen CD59 with Disease.

Authors:  Christof Weinstock
Journal:  Transfus Med Hemother       Date:  2022-01-13       Impact factor: 3.747

7.  Activated C3 (C3b) in the nephritic glomerulus.

Authors:  C Pan; C F Strife; A J McAdams; C D West
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

8.  Isolation and characterization of a membrane protein from rat erythrocytes which inhibits lysis by the membrane attack complex of rat complement.

Authors:  T R Hughes; S J Piddlesden; J D Williams; R A Harrison; B P Morgan
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

9.  Inhibition of immune haemolysis by a serum factor found in C3-deficient subjects.

Authors:  H Kitamura; M Tsuboi
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

10.  Isolation and characterization of a membrane-attack-complex-inhibiting protein present in human serum and other biological fluids.

Authors:  M J Watts; J R Dankert; E P Morgan
Journal:  Biochem J       Date:  1990-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.